Literature DB >> 30115999

Osteopontin protects against lung injury caused by extracellular histones.

Gopinath Kasetty1, Praveen Papareddy2, Ravi K V Bhongir3, Mohamad N Ali3, Michiko Mori4, Malgorzata Wygrecka5, Jonas S Erjefält4, Anna Hultgårdh-Nilsson4, Lena Palmberg6, Heiko Herwald2, Arne Egesten3.   

Abstract

Extracellular histones are present in the airways because of cell death occurring during inflammation. They promote inflammation and cause tissue damage due to their cationic nature. The anionic phosphoglycoprotein osteopontin (OPN) is expressed at high levels during airway inflammation and has been ascribed both pro- and anti-inflammatory roles. In this study, it was hypothesized that OPN may neutralize the harmful activities of extracellular histones at the airway mucosal surface. In a model of histone-induced acute lung injury, OPN-/- mice showed increased inflammation and tissue injury, and succumbed within 24 h, whereas wild-type mice showed lower degrees of inflammation and no mortality. In lipopolysaccharide-induced acute lung injury, wild-type mice showed less inflammation and tissue injury than OPN-/- mice. In bronchoalveolar lavage fluid from ARDS patients, high levels of OPN and also histone-OPN complexes were detected. In addition, OPN bound to histones with high affinity in vitro, resulting in less cytotoxicity and reduced formation of tissue-damaging neutrophil extracellular traps (NETs). The interaction between OPN and histones was dependent on posttranslational modification of OPN, i.e., phosphorylation. The findings demonstrate a novel role for OPN, modulating the pro-inflammatory and cytotoxic properties of free histones.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30115999     DOI: 10.1038/s41385-018-0079-3

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  57 in total

Review 1.  Neutrophil activation and acute lung injury.

Authors:  W L Lee; G P Downey
Journal:  Curr Opin Crit Care       Date:  2001-02       Impact factor: 3.687

2.  Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Robert Ruemmler; Norman F Russkamp; Firas S Zetoune; J Vidya Sarma; Theodore J Standiford; Peter A Ward
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

Review 3.  The acute respiratory distress syndrome: pathogenesis and treatment.

Authors:  Michael A Matthay; Rachel L Zemans
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  Selective Biological Responses of Phagocytes and Lungs to Purified Histones.

Authors:  Fatemeh Fattahi; Jamison J Grailer; Hope Lu; Rachel S Dick; Michella Parlett; Firas S Zetoune; Gabriel Nuñez; Peter A Ward
Journal:  J Innate Immun       Date:  2017-02-08       Impact factor: 7.349

5.  Acute lung injury induced by lipopolysaccharide is independent of complement activation.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Stephanie R McGuire; Laszlo M Hoesel; Kyros Ipaktchi; Firas S Zetoune; J Vidya Sarma; Lin Leng; Markus S Huber-Lang; Thomas A Neff; Richard Bucala; Peter A Ward
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?

Authors:  L Gattinoni; P Pelosi; P M Suter; A Pedoto; P Vercesi; A Lissoni
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

7.  Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.

Authors:  Teluguakula Narasaraju; Edwin Yang; Ramar Perumal Samy; Huey Hian Ng; Wee Peng Poh; Audrey-Ann Liew; Meng Chee Phoon; Nico van Rooijen; Vincent T Chow
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

Review 8.  Acute lung injury and the role of histones.

Authors:  Peter A Ward; Jamison J Grailer
Journal:  Transl Respir Med       Date:  2014-01-03

9.  Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury.

Authors:  Shuai Liu; Xiaoli Su; Pinhua Pan; Lemeng Zhang; Yongbin Hu; Hongyi Tan; Dongdong Wu; Ben Liu; Haitao Li; Haosi Li; Yi Li; Minhui Dai; Yuanyuan Li; Chengping Hu; Allan Tsung
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

Review 10.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

View more
  5 in total

1.  Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure.

Authors:  Fatima Zohra Khamissi; Liang Ning; Eirini Kefaloyianni; Hao Dun; Akshayakeerthi Arthanarisami; Amy Keller; Jeffrey J Atkinson; Wenjun Li; Brian Wong; Sabine Dietmann; Kory Lavine; Daniel Kreisel; Andreas Herrlich
Journal:  Sci Adv       Date:  2022-02-25       Impact factor: 14.136

2.  Pan-Cancer Analysis Reveals a Distinct Neutrophil Extracellular Trap-Associated Regulatory Pattern.

Authors:  Xiao-Tian Shen; Sun-Zhe Xie; Jing Xu; Lu-Yu Yang; Lun-Xiu Qin
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

Review 3.  Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.

Authors:  Anne-Sophie Lamort; Ioanna Giopanou; Ioannis Psallidas; Georgios T Stathopoulos
Journal:  Cells       Date:  2019-08-02       Impact factor: 6.600

4.  Osteopontin Expression in Small Airway Epithelium in Copd is Dependent on Differentiation and Confined to Subsets of Cells.

Authors:  Mohamad N Ali; Michiko Mori; Tinne C J Mertens; Premkumar Siddhuraj; Jonas S Erjefält; Patrik Önnerfjord; Pieter S Hiemstra; Arne Egesten
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

Review 5.  Extracellular histones in lung dysfunction: a new biomarker and therapeutic target?

Authors:  Pratap Karki; Konstantin G Birukov; Anna A Birukova
Journal:  Pulm Circ       Date:  2020-11-10       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.